Literature DB >> 17170050

Use of infliximab in juvenile onset rheumatological disease-associated refractory uveitis: efficacy in joint and ocular disease.

Srilakshmi M Sharma, Athimalaipet V Ramanan, Philip Riley, Andrew D Dick.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17170050      PMCID： PMC1954647          DOI： 10.1136/ard.2006.065441

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  8 in total

1.  Infliximab for juvenile idiopathic arthritis-associated uveitis.

Authors:  Josephine C Richards; Mei-Ling Tay-Kearney; Kevin Murray; Prue Manners
Journal:  Clin Exp Ophthalmol       Date:  2005-10       Impact factor: 4.207

2.  A prospective trial of infliximab therapy for refractory uveitis: preliminary safety and efficacy outcomes.

Authors:  Eric B Suhler; Justine R Smith; Michael S Wertheim; Andreas K Lauer; Daryl E Kurz; Terri D Pickard; James T Rosenbaum
Journal:  Arch Ophthalmol       Date:  2005-07

3.  Differential efficacy of tumor necrosis factor inhibition in the management of inflammatory eye disease and associated rheumatic disease.

Authors:  J R Smith; R D Levinson; G N Holland; D A Jabs; M R Robinson; S M Whitcup; J T Rosenbaum
Journal:  Arthritis Rheum       Date:  2001-06

4.  Retrospective case review of pediatric patients with uveitis treated with infliximab.

Authors:  Ravindran T Rajaraman; Yukiko Kimura; Suzanne Li; Kathleen Haines; David S Chu
Journal:  Ophthalmology       Date:  2006-01-10       Impact factor: 12.079

5.  Impact of anti-TNF treatment on growth in severe juvenile idiopathic arthritis.

Authors:  P Tynjälä; P Lahdenne; P Vähäsalo; H Kautiainen; V Honkanen
Journal:  Ann Rheum Dis       Date:  2006-01-31       Impact factor: 19.103

6.  A randomized, placebo-controlled, double-masked clinical trial of etanercept for the treatment of uveitis associated with juvenile idiopathic arthritis.

Authors:  Janine A Smith; Darby J S Thompson; Scott M Whitcup; Eric Suhler; Grace Clarke; Susan Smith; Michael Robinson; Jonghyeon Kim; Karyl S Barron
Journal:  Arthritis Rheum       Date:  2005-02-15

7.  Tumour necrosis factor alpha inhibitors in the treatment of childhood uveitis.

Authors:  R K Saurenmann; A V Levin; J B Rose; S Parker; T Rabinovitch; P N Tyrrell; B M Feldman; R M Laxer; R Schneider; E D Silverman
Journal:  Rheumatology (Oxford)       Date:  2006-02-03       Impact factor: 7.580

Review 8.  Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop.

Authors:  Douglas A Jabs; Robert B Nussenblatt; James T Rosenbaum
Journal:  Am J Ophthalmol       Date:  2005-09       Impact factor: 5.258
  8 in total
  13 in total

Review 1.  Anti-inflammatory treatment of uveitis with biologicals: new treatment options that reflect pathogenetic knowledge of the disease.

Authors:  Arnd Heiligenhaus; Stephan Thurau; Maren Hennig; Rafael S Grajewski; Gerhild Wildner
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-08-25       Impact factor: 3.117

Review 2.  Advances in the diagnosis and immunotherapy for ocular inflammatory disease.

Authors:  Steven Yeh; Lisa J Faia; Robert B Nussenblatt
Journal:  Semin Immunopathol       Date:  2008-03-05       Impact factor: 9.623

Review 3.  Non-infectious pediatric uveitis: an update on immunomodulatory management.

Authors:  Srilakshmi M Sharma; Andrew D Dick; Athimalaipet V Ramanan
Journal:  Paediatr Drugs       Date:  2009       Impact factor: 3.022

Review 4.  The Future Is Now: Biologics for Non-Infectious Pediatric Anterior Uveitis.

Authors:  Melissa A Lerman; C Egla Rabinovich
Journal:  Paediatr Drugs       Date:  2015-08       Impact factor: 3.022

Review 5.  [Therapy for childhood uveitis: biologics: too often--too late?].

Authors:  F Mackensen; T Lutz
Journal:  Ophthalmologe       Date:  2011-03       Impact factor: 1.059

Review 6.  The Use of Biologic Therapies in Uveitis.

Authors:  Sergio Schwartzman; Monica Schwartzman
Journal:  Clin Rev Allergy Immunol       Date:  2015-12       Impact factor: 8.667

Review 7.  Evidence-based, interdisciplinary guidelines for anti-inflammatory treatment of uveitis associated with juvenile idiopathic arthritis.

Authors:  A Heiligenhaus; H Michels; C Schumacher; I Kopp; U Neudorf; T Niehues; H Baus; M Becker; B Bertram; G Dannecker; C Deuter; I Foeldvari; M Frosch; G Ganser; M Gaubitz; G Gerdes; G Horneff; A Illhardt; F Mackensen; K Minden; U Pleyer; M Schneider; N Wagner; M Zierhut
Journal:  Rheumatol Int       Date:  2011-11-15       Impact factor: 2.631

Review 8.  Biologic agents in experimental autoimmune uveitis.

Authors:  Gian Paolo Giuliari; Ama Sadaka; David M Hinkle
Journal:  Int Ophthalmol       Date:  2013-03-14       Impact factor: 2.031

Review 9.  Judicious use of biologicals in juvenile idiopathic arthritis.

Authors:  Yongdong Zhao; Carol Wallace
Journal:  Curr Rheumatol Rep       Date:  2014-11       Impact factor: 4.592

10.  Response of pediatric uveitis to tumor necrosis factor-α inhibitors.

Authors:  Melissa A Lerman; Jon M Burnham; Peter Y Chang; Ebenezer Daniel; C Stephen Foster; Sean Hennessy; Douglas A Jabs; Marshall M Joffe; R Oktay Kaçmaz; Grace A Levy-Clarke; Monte D Mills; Robert B Nussenblatt; James T Rosenbaum; Eric B Suhler; Jennifer E Thorne; John H Kempen
Journal:  J Rheumatol       Date:  2013-07-01       Impact factor: 4.666
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.